Abstract
Current evidence suggests that high uric acid levels are associated with accelerated renal damage. However, the clinical impact of serum uric acid level on patients with microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA) is unknown. We aimed to evaluate the impact of hyperuricemia on such patients. A retrospective study was performed to obtain patients’ demographic, clinical, and laboratory data from when they were diagnosed with MPA and GPA. Multivariable logistic regression and Cox hazard model analyses were performed to evaluate factors associated with hyperuricemia at diagnosis and predictive factors of end-stage renal disease (ESRD) development. Among 156 patients, 35 (22.4%) had hyperuricemia at baseline. Hyperuricemic patients had renal manifestation and impaired renal function more frequently than non-hyperuricemic patients. Logistic regression analysis revealed that serum creatinine was significantly associated with hyperuricemia at diagnosis [odds ratio 1.995; 95% confidence interval (CI), 1.503–2.648; P < 0.001]. Cox hazard model analysis revealed that body mass index and serum creatinine were significantly associated with ESRD when all variables were included, but hyperuricemia was independently associated with ESRD [hazard ratio (HR), 3.799; 95% CI 1.719–8.222; P < 0.001) when serum creatinine was excluded. Additionally, in a subgroup analysis of patients with decreased glomerular filtration rates (GFRs), serum uric acid was the sole predictor of ESRD (HR, 1.243; 95% CI 1.048–1.475; P = 0.013). Hyperuricemia is associated with renal damage and ESRD occurrence in MPA and GPA patients. Serum uric acid level is associated with ESRD occurrence in patients with decreased GFRs.
Similar content being viewed by others
References
Jennette JC, Falk RJ, Bacon PA et al (2013) 2012 Revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65:1–11. https://doi.org/10.1002/art.37715
Kallenberg CG (2014) Key advances in the clinical approach to ANCA-associated vasculitis. Nat Rev Rheumatol 10:484–493. https://doi.org/10.1038/nrrheum.2014.104
Schonermarck U, Gross WL, de Groot K (2014) Treatment of ANCA-associated vasculitis. Nat Rev Nephrol 10:25–36. https://doi.org/10.1038/nrneph.2013.225
Rowaiye OO, Kusztal M, Klinger M (2015) The kidneys and ANCA-associated vasculitis: from pathogenesis to diagnosis. Clin Kidney J 8:343–350. https://doi.org/10.1093/ckj/sfv020
Moiseev S, Novikov P, Jayne D, Mukhin N (2017) End-stage renal disease in ANCA-associated vasculitis. Nephrol Dial Transplant 32:248–253. https://doi.org/10.1093/ndt/gfw046
Lieberthal JG, Cuthbertson D, Carette S et al (2013) Urinary biomarkers in relapsing antineutrophil cytoplasmic antibody-associated vasculitis. J Rheumatol 40:674–683. https://doi.org/10.3899/jrheum.120879
Chen M, Wang F, Zhao MH (2009) Circulating neutrophil gelatinase-associated lipocalin: a useful biomarker for assessing disease activity of ANCA-associated vasculitis. Rheumatology (Oxford) 48:355–358. https://doi.org/10.1093/rheumatology/ken500
Weidner S, Geuss S, Hafezi-Rachti S, Wonka A, Rupprecht HD (2004) ANCA-associated vasculitis with renal involvement: an outcome analysis. Nephrol Dial Transplant 19:1403–1411. https://doi.org/10.1093/ndt/gfh161
Ejaz AA, Mu W, Kang DH et al (2007) (2007) Could uric acid have a role in acute renal failure? Clin J Am Soc Nephrol 2:16–21. https://doi.org/10.2215/cjn.00350106
Sanchez-Lozada LG, Tapia E, Santamaria J, Avila-Casado C, Soto V, Nepomuceno T, Rodriguez-Iturbe B, Johnson RJ, Herrera-Acosta J (2005) Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int 67:237–247. https://doi.org/10.1111/j.1523-1755.2005.00074.x
Roncal CA, Mu W, Croker B, Reungjui S, Ouyang X, Tabah-Fisch I, Johnson RJ, Ejaz AA (2007) Effect of elevated serum uric acid on cisplatin-induced acute renal failure. Am J Physiol Renal Physiol 292:F116–122. https://doi.org/10.1152/ajprenal.00160.2006
Calich AL, Borba EF, Ugolini-Lopes MR, da Rocha LF, Bonfa E, Fuller R (2018) Serum uric acid levels are associated with lupus nephritis in patients with normal renal function. Clin Rheumatol 37:1223–1228. https://doi.org/10.1007/s10067-018-3991-8
Daoussis D, Panoulas V, Toms T, John H, Antonopoulos I, Nightingale P, Douglas KM, Klocke R, Kitas GD (2009) Uric acid is a strong independent predictor of renal dysfunction in patients with rheumatoid arthritis. Arthritis Res Ther 11:R116. https://doi.org/10.1186/ar2775
Yu KH, Kuo CF, Luo SF, See LC, Chou IJ, Chang HC, Chiou MJ (2012) Risk of end-stage renal disease associated with gout: a nationwide population study. Arthritis Res Ther 14:R83. https://doi.org/10.1186/ar3806
Richette P, Doherty M, Pascual E et al (2017) 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis 76:29–42. https://doi.org/10.1136/annrheumdis-2016-209707
Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W, Mahr A, Segelmark M, Cohen-Tervaert JW, Scott D (2007) Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66:222–227. https://doi.org/10.1136/ard.2006.054593
Leavitt RY, Fauci AS, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 33:1101–1107. https://doi.org/10.1002/art.1780330807
Mukhtyar C, Lee R, Brown D et al (2009) Modification and validation of the Birmingham vasculitis activity score (version 3). Ann Rheum Dis 68:1827–1832. https://doi.org/10.1136/ard.2008.101279
Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Le Toumelin P (2011) The five-factor score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore) 90:19–27. https://doi.org/10.1097/MD.0b013e318205a4c6
Stone JH, Hoffman GS, Merkel PA et al (2001) A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score International Network for the Study of the Systemic Vasculitides (INSSYS). Arthritis Rheum 44:912–920. https://doi.org/10.1002/1529-0131(200104)44:4%3c912::Aid-anr148%3e3.0.Co;2-5
Bossuyt X, Cohen Tervaert JW, Arimura Y et al (2017) Position paper: revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis. Nat Rev Rheumatol 13:683–692. https://doi.org/10.1038/nrrheum.2017.140
Jin M, Yang F, Yang I, Yin Y, Luo JJ, Wang H, Yang XF (2012) Uric acid, hyperuricemia and vascular diseases. Front Biosci (Landmark Ed) 17:656–669
(2013) Chapter 1: Definition and classification of CKD. Kidney Int Suppl (2011) 2013;3:19–62. https://doi.org/10.1038/kisup.2012.64
Mukhtyar C, Hellmich B, Jayne D, Flossmann O, Luqmani R (2006) Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis. Clin Exp Rheumatol 24:93–98
Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S (2004) Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 44:642–650
Iseki K (2018) Significance of hyperuricemia among community-based screening participants. Contrib Nephrol 192:41–47. https://doi.org/10.1159/000484277
Benn CL, Dua P, Gurrell R, Loudon P, Pike A, Storer RI, Vangjeli C (2018) Physiology of hyperuricemia and urate-lowering treatments. Front Med (Lausanne) 5:160. https://doi.org/10.3389/fmed.2018.00160
Oh TR, Choi HS, Kim CS, Bae EH, Ma SK, Sung SA, Kim YS, Oh KH, Ahn C, Kim SW (2019) Hyperuricemia has increased the risk of progression of chronic kidney disease: propensity score matching analysis from the KNOW-CKD study. Sci Rep 9:6681. https://doi.org/10.1038/s41598-019-43241-3
Jennette JC, Falk RJ, Hu P, Xiao H (2013) Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis. Annu Rev Pathol 8:139–160. https://doi.org/10.1146/annurev-pathol-011811-132453
Jennette JC, Falk RJ (2014) Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease. Nat Rev Rheumatol 10:463–473. https://doi.org/10.1038/nrrheum.2014.103
Gibson TJ (2013) Hypertension, its treatment, hyperuricaemia and gout. Curr Opin Rheumatol 25:217–222. https://doi.org/10.1097/BOR.0b013e32835cedd4
McAdams-DeMarco MA, Maynard JW, Baer AN, Coresh J (2012) Hypertension and the risk of incident gout in a population-based study: the atherosclerosis risk in communities cohort. J Clin Hypertens (Greenwich) 14:675–679. https://doi.org/10.1111/j.1751-7176.2012.00674.x
Li C, Hsieh MC, Chang SJ (2013) Metabolic syndrome, diabetes, and hyperuricemia. Curr Opin Rheumatol 25:210–216. https://doi.org/10.1097/BOR.0b013e32835d951e
Kanbay M, Segal M, Afsar B, Kang DH, Rodriguez-Iturbe B, Johnson RJ (2013) The role of uric acid in the pathogenesis of human cardiovascular disease. Heart 99:759–766. https://doi.org/10.1136/heartjnl-2012-302535
Kleber ME, Delgado G, Grammer TB, Silbernagel G, Huang J, Kramer BK, Ritz E, Marz W (2015) Uric acid and cardiovascular events: a mendelian randomization study. J Am Soc Nephrol 26:2831–2838. https://doi.org/10.1681/asn.2014070660
Albert D, Scudder PN, Bagley P, Saag KG (2019) Vascular consequences of hyperuricemia and hypouricemia. Rheum Dis Clin North Am 45:453–464. https://doi.org/10.1016/j.rdc.2019.04.005
Yun HR, Kim H, Park JT et al (2018) Obesity, metabolic abnormality, and progression of CKD. Am J Kidney Dis 72:400–410. https://doi.org/10.1053/j.ajkd.2018.02.362
Kim H, Kim J, Seo C et al (2017) Body mass index is inversely associated with mortality in patients with acute kidney injury undergoing continuous renal replacement therapy. Kidney Res Clin Pract 36:39–47. https://doi.org/10.23876/j.krcp.2017.36.1.39
Lu JL, Kalantar-Zadeh K, Ma JZ, Quarles LD, Kovesdy CP (2014) Association of body mass index with outcomes in patients with CKD. J Am Soc Nephrol 25:2088–2096. https://doi.org/10.1681/asn.2013070754
Babitt JL, Lin HY (2012) Mechanisms of anemia in CKD. J Am Soc Nephrol 23:1631–1634. https://doi.org/10.1681/asn.2011111078
Acknowledgements
This study was supported for English editing service from Editage.
Funding
This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) and funded by the Ministry of Education (2017R1D1A1B03029050) and a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health and Welfare, Republic of Korea (HI14C1324).
Author information
Authors and Affiliations
Contributions
Conceptualization: HCK, SSA and SWL. Data curation: SSA, BWY and JY. Formal analysis: JY and SMJ. Methodology: SSA, JJS and SWL. Project administration: HCK and SSA. Supervision: YBP and SWL. Writing—original draft: HCK and SWL. Writing—review and editing: SSA, BWY, JY, SMJ, JJS, YBP and SWL. All authors take full responsibility for the integrity of the study and final manuscript.
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflict of interest.
Ethics approval
This study was performed in accordance with the principles set by the Declaration of Helsinki, and was approved by the Institutional Review Board (IRB) of Severance Hospital (IRB number: 4-2017-0673).
Data and/or Code availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Kwon, H.C., Ahn, S.S., Yoo, BW. et al. Hyperuricemia is associated with decreased renal function and occurrence of end-stage renal disease in patients with microscopic polyangiitis and granulomatosis with polyangiitis: a retrospective study. Rheumatol Int 40, 1089–1099 (2020). https://doi.org/10.1007/s00296-020-04579-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-020-04579-4